LEN vs OM · rev $34.19B vs rev $113.7M
LEN (LEN) versus Outset Medical Inc (OM) — a side-by-side from cached financials, not a winner call.
LEN (LEN) common stock.
Outset Medical Inc (OM) is a medical devices company listed on NASDAQ.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
Latest reported OM revenue for 2024-12-31 was $113.7M. Net income was -$128.0M. Revenue was down 12.8% from 2023-12-31 to 2024-12-31. OM currently screens at market cap $74.5M.
LEN currently screens at market cap $0. OM currently screens at market cap $74.5M.
Not investment advice. Open the LEN and OM stock pages for the full models.
Not investment advice.